House passes drug pricing bill, setting baseline for future price control legislation

The House of Representatives Thursday passed H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, in a 230-192 vote.

Although the bill will not be considered by the Senate and the Trump administration has

Read the full 367 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE